Evidence against resveratrol as a viable therapy for the rescue of defective Δf508 CFTR

Biochimica et Biophysica Acta - General Subjects

Volumn 1850, Issue 11, 2015, Pages 2377-2384

  Jai, Ying ^a   Shah, Kalpit ^a   Bridges, Robert J ^a   Bradbury, Neil A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

CFTR; Conductance; Cystic fibrosis; Human airway cell culture; Resveratrol

Indexed keywords

AMILORIDE; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MESSENGER RNA; RESVERATROL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508; STILBENE DERIVATIVE;

ARTICLE; BIOGENESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM TRANSPORT; GENETICS; HEK293 CELL LINE; MUTATION; PHYSIOLOGY;

CYCLIC AMP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HEK293 CELLS; HUMANS; MUTATION; STILBENES;

EID: 84941595661     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.08.020     Document Type: Article

References (60)

1. M. Welsh, and B. Ramsey Cystic Fibrosis C. Scriver, A. Beaudet, D. Valle, The Metabolic and Molecular Basis of Inherited Disease 2001 McGraw-Hill New York 5121 5188
2. J.M. Pilewski, and R.A. Frizzell Role of CFTR in airway disease Physiol. Rev. 79 1999 S215 S255
3. J.L. Bobadilla, M. Macek Jr., J.P. Fine, and P.M. Farrell Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening Hum. Mutat. 19 2002 575 606
4. J.R. Riordan Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein Am. J. Hum. Genet. 64 1999 1499 1504
5. R.R. Kopito Biosynthesis and degradation of CFTR Physiol. Rev. 79 1999 S167 S173
6. G.M. Denning, M.P. Anderson, J.F. Amara, J. Marshall, A.E. Smith, and M.J. Welsh Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358 1992 761 764
7. H. Yang, A.A. Shelat, R.K. Guy, V.S. Gopinath, T. Ma, K. Du, G.L. Lukacs, A. Taddei, C. Folli, N. Pedemonte, L.J. Galietta, and A.S. Verkman Nanomolar affinity small molecule correctors of defective delta F508-CFTR chloride channel gating J. Biol. Chem. 278 2003 35079 35085
8. F. Van Goor, K.S. Straley, D. Cao, J. Gonzalez, S. Hadida, A. Hazlewood, J. Joubran, T. Knapp, L.R. Makings, M. Miller, T. Neuberger, E. Olson, V. Panchenko, J. Rader, A. Singh, J.H. Stack, R. Tung, P.D. Grootenhuis, and P. Negulescu Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 L1117 L1130
9. S. Pasyk, S. Molinski, W. Yu, P.D. Eckford, and C.E. Bear Identification and validation of hits from high throughput screens for CFTR modulators Curr. Pharm. Des. 18 2012 628 641
10. N. Hamdaoui, M. Baudoin-Legros, M. Kelly, A. Aissat, S. Moriceau, D.L. Vieu, J. Colas, J. Fritsch, A. Edelman, and G. Planelles Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1 Br. J. Pharmacol. 163 2011 876 886
11. N.S. Alexander, N. Hatch, S. Zhang, D. Skinner, J. Fortenberry, E.J. Sorscher, and B.A. Woodworth Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium Laryngoscope 121 2011 1313 1319
12. S. Zhang, A.C. Blount, C.M. McNicholas, D.F. Skinner, M. Chestnut, J.C. Kappes, E.J. Sorscher, and B.A. Woodworth Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability PLoS One 8 2013 e81589
13. B. Dhooghe, C. Bouckaert, A. Capron, P. Wallemacq, T. Leal, and S. Noel Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice Biol. Open 2015
14. M. Lee, S. Kim, O.K. Kwon, S.R. Oh, H.K. Lee, and K. Ahn Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma Int. Immunopharmacol. 9 2009 418 424
15. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87
16. T. Walle Bioavailability of resveratrol Ann. N. Y. Acad. Sci. 1215 2011 9 15
17. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. Biol. Fate Chem. 32 2004 1377 1382
18. M.E. Juan, and J.M. Planas Trans-resveratrol oral administration does not affect the enzymatic activities in rat small intestine J. Physiol. Biochem. 58 2002 59 60
19. M.E. Juan, M.P. Vinardell, and J.M. Planas The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful J. Nutr. 132 2002 257 260
20. K. Bisht, K.H. Wagner, and A.C. Bulmer Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds Toxicology 278 2010 88 100
21. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J. Immunol. 164 2000 6509 6519
22. S. Hadida-Ruah, F. Van Goor, M.T. Miller, J. McCartney, and V. Arumugam Modulators of cystic fibrosis transmembrane conductance regulator 2013
23. P.D. Eckford, M. Ramjeesingh, S. Molinski, S. Pasyk, J.F. Dekkers, C. Li, S. Ahmadi, W. Ip, T.E. Chung, K. Du, H. Yeger, J. Beekman, T. Gonska, and C.E. Bear VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface Chem. Biol. 21 2014 666 678
24. M.R. Silvis, J.A. Picciano, C. Bertrand, K. Weixel, R.J. Bridges, and N.A. Bradbury A mutation in the cystic fibrosis transmembrane conductance regulator generates a novel internalization sequence and enhances endocytic rates J. Biol. Chem. 278 2003 11554 11560
25. K. Shah, C.E. McCormack, and N.A. Bradbury Do you know the sex of your cells? Am. J. Physiol. Cell Physiol. 306 2014 C3 C18
26. C.L. Bell, and P.M. Quinton T84 cells: anion selectivity demonstrates expression of Cl-conductance affected in cystic fibrosis Am. J. Phys. 262 1992 C555 C562
27. J.A. Wagner, T.V. McDonald, P.T. Nghiem, A.W. Lowe, H. Schulman, D.C. Gruenert, L. Stryer, and P. Gardner Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents Proc. Natl. Acad. Sci. U. S. A. 89 1992 6785 6789
28. L.J. Galietta, S. Lantero, A. Gazzolo, O. Sacco, L. Romano, G.A. Rossi, and O. Zegarra-Moran An improved method to obtain highly differentiated monolayers of human bronchial epithelial cells In Vitro Cell. Dev. Biol. Anim. 34 1998 478 481
29. F. Van Goor, S. Hadida, P.D. Grootenhuis, B. Burton, D. Cao, T. Neuberger, A. Turnbull, A. Singh, J. Joubran, A. Hazlewood, J. Zhou, J. McCartney, V. Arumugam, C. Decker, J. Yang, C. Young, E.R. Olson, J.J. Wine, R.A. Frizzell, M. Ashlock, and P. Negulescu Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 Proc. Natl. Acad. Sci. U. S. A. 106 2009 18825 18830
30. A.K. Singh, K. Tasken, W. Walker, R. Frizzell, S.C. Watkins, R.J. Bridges, and N.A. Bradbury Characterization of PKA isoforms and kinase-dependent activation of chloride secretion in T84 cells Am. J. Phys. 275 1998 C562 C570
31. S.J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams, H. Luo, H. Ke, H. Rehmann, R. Taussig, A.L. Brown, M.K. Kim, M.A. Beaven, A.B. Burgin, V. Manganiello, and J.H. Chung Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 148 2012 421 433
32. M.E. Egan, M. Pearson, S.A. Weiner, V. Rajendran, D. Rubin, J. Glockner-Pagel, S. Canny, K. Du, G.L. Lukacs, and M.J. Caplan Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects Science 304 2004 600 602
33. A. Schmidt, L.K. Hughes, Z. Cai, F. Mendes, H. Li, D.N. Sheppard, and M.D. Amaral Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator Br. J. Pharmacol. 153 2008 1311 1323
34. H. Fischer, and B. Illek Activation of the CFTR Cl- channel by trimethoxyflavone in vitro and in vivo Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 22 2008 685 692
35. Y. Song, N.D. Sonawane, D. Salinas, L. Qian, N. Pedemonte, L.J. Galietta, and A.S. Verkman Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models J. Biol. Chem. 279 2004 40629 40633
36. I. Blumenstein, B. Keseru, F. Wolter, and J. Stein The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 11 2005 5651 5656
37. A.A. Qureshi, X.Q. Guan, J.C. Reis, C.J. Papasian, S. Jabre, D.C. Morrison, and N. Qureshi Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor Lipids Health Dis. 11 2012 76
38. R.A. Schoumacher, J. Ram, M.C. Iannuzzi, N.A. Bradbury, R.W. Wallace, C.T. Hon, D.R. Kelly, S.M. Schmid, F.B. Gelder, T.A. Rado, and et al. A cystic fibrosis pancreatic adenocarcinoma cell line Proc. Natl. Acad. Sci. U. S. A. 87 1990 4012 4016
39. P. Liu, H. Liang, Q. Xia, P. Li, H. Kong, P. Lei, S. Wang, and Z. Tu Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression Clin. Transl. Oncol. 15 2013 741 746
40. N.C. Chang, M. Nguyen, M. Germain, and G.C. Shore Antagonism of beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1 EMBO J. 29 2010 606 618
41. M.C. Maiuri, A. Criollo, and G. Kroemer Crosstalk between apoptosis and autophagy within the beclin 1 interactome EMBO J. 29 2010 515 516
42. S.A. Malik, I. Orhon, E. Morselli, A. Criollo, S. Shen, G. Marino, A. BenYounes, P. Benit, P. Rustin, M.C. Maiuri, and G. Kroemer BH3 mimetics activate multiple pro-autophagic pathways Oncogene 30 2011 3918 3929
43. B. Yu, Y. Zhang, Y. Sui, S. Yang, J. Luan, X. Wang, T. Ma, and H. Yang Potentiation of mutant CFTR Cl- channel currents by the naturally occurring stilbene compound resveratrol Pharmazie 68 2013 877 881
44. N. Qureshi, D.C. Morrison, and J. Reis Proteasome protease mediated regulation of cytokine induction and inflammation Biochim. Biophys. Acta 1823 2012 2087 2093
45. W.R. Skach Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator Kidney Int. 57 2000 825 831
46. M. Wilke, A. Bot, H. Jorna, B.J. Scholte, and H.R. de Jonge Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors PLoS One 7 2012 e52070
47. S. Ye, K. Cihil, D.B. Stolz, J.M. Pilewski, B.A. Stanton, and A. Swiatecka-Urban c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells J. Biol. Chem. 285 2010 27008 27018
48. T. Okiyoneda, H. Barriere, M. Bagdany, W.M. Rabeh, K. Du, J. Hohfeld, J.C. Young, and G.L. Lukacs Peripheral protein quality control removes unfolded CFTR from the plasma membrane Science 329 2010 805 810
49. A.M. El-Mowafy, and M. Alkhalaf Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism Carcinogenesis 24 2003 869 873
50. D.W. Park, K. Baek, J.R. Kim, J.J. Lee, S.H. Ryu, B.R. Chin, and S.H. Baek Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1 Exp. Mol. Med. 41 2009 171 179
51. G.J. Clesham, H. Browne, S. Efstathiou, and P.L. Weissberg Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells Circ. Res. 79 1996 1188 1195
52. N. Pittman, G. Shue, N.S. LeLeiko, and M.J. Walsh Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation J. Biol. Chem. 270 1995 28848 28857
53. J.A. Johnston, C.L. Ward, and R.R. Kopito Aggresomes: a cellular response to misfolded proteins J. Cell Biol. 143 1998 1883 1898
54. L. Fu, A. Rab, L. Tang, Z. Bebok, S.M. Rowe, R. Bartoszewski, and J.F. Collawn DeltaF508 CFTR surface stability is regulated by DAB2 and CHIP-mediated ubiquitination in post-endocytic compartments PLoS One 10 2015 e0123131
55. K. Shah, Y. Cheng, B. Hahn, R. Bridges, N.A. Bradbury, and D.M. Mueller Synonymous codon usage affects the expression of wild type and F508del CFTR J. Mol. Biol. 2015
56. N.A. Bradbury, and M.A. McPherson Isoproterenol-induced desensitization of mucin release in isolated rat submandibular acini Biochim. Biophys. Acta 970 1988 363 370
57. Y. Zhang, B. Yu, Y. Sui, X. Gao, H. Yang, and T. Ma Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from Chinese medicinal plants PLoS One 9 2014 e94302
58. D.M. Cholon, N.L. Quinney, M.L. Fulcher, C.R. Esther Jr., J. Das, N.V. Dokholyan, S.H. Randell, R.C. Boucher, and M. Gentzsch Potentiator ivacaftor abrogates pharmacological correction of DeltaF508 CFTR in cystic fibrosis Sci. Transl. Med. 6 2014 (246ra296)
59. R.C. Boucher, M.J. Stutts, M.R. Knowles, L. Cantley, and J.T. Gatzy Na + transport in cystic fibrosis respiratory epithelia Abnorm. Basal Rate Response Adenylate Cyclase Activation J. Clin. Invest. 78 1986 1245 1252
60. L.H. Burch, C.R. Talbot, M.R. Knowles, C.M. Canessa, B.C. Rossier, and R.C. Boucher Relative expression of the human epithelial Na + channel subunits in normal and cystic fibrosis airways Am. J. Phys. 269 1995 C511 C518